Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingSep 30, 2026Reliable -1 LaboratoriesLack of Assurance of SterilitySterling Pharmaceutical Services LLC · D-0856-2026Class IIOngoingSep 30, 2026AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%Lack of Assurance of SterilitySterling Pharmaceutical Services LLC · D-0855-2026Class IIOngoingSep 30, 2026MENOW SUNSCREEN PRESSED POWDER SPF35 PA+++cGMP DeviationsSHANTOU Qiwei industrial Co., Ltd · D-0854-2026Class IOngoingSep 23, 2026Thyroid TabletsSuperpotent DrugVitruvias Therapeutics Inc · D-0866-2026Class IIOngoingSep 23, 2026Dopamine HCl InjLack of Assurance of SterilityPfizer · D-0853-2026Class IIOngoingSep 23, 2026Chlorthalidone TabletsFailed Dissolution SpecificationsInventia Healthcare Limited · D-0852-2026Class IIOngoingSep 23, 2026Lidocaine Ointment USPFailed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).Sun Pharma /Taro · D-0848-2026Class IIOngoingSep 23, 2026Fluphenazine HCl ElixirFailed Stability SpecificationsSafecor Health, LLC · D-0846-2026Class IIOngoingSep 23, 2026Fluphenazine HCl ElixirFailed Stability SpecificationsSafecor Health, LLC · D-0845-2026Class IIOngoingSep 23, 2026Fluphenazine HCl ElixirFailed Stability SpecificationsSafecor Health, LLC · D-0844-2026Class IIOngoingSep 23, 2026Fluphenazine HCl ElixirFailed Stability SpecificationsSafecor Health, LLC · D-0843-2026Class IIOngoingSep 23, 2026Fluphenazine HCl ElixirFailed Stability SpecificationsSafecor Health, LLC · D-0842-2026Class IIOngoingSep 23, 2026Fluphenazine HCl ElixirFailed Stability SpecificationsSafecor Health, LLC · D-0841-2026Class IOngoingSep 16, 20260.9% Sodium Chloride InjectionPresence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyreneB Braun Medical Inc · D-0869-2026Class IOngoingSep 16, 2026Epinephrine InjectionPresence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and...American Regent, Inc. · D-0865-2026Class IIOngoingSep 16, 2026fentaNYL CitrateLabeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry...OurPharma LLC · D-0864-2026Class IOngoingSep 16, 2026Dextrose InjectionPresence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.Baxter Healthcare Corporation · D-0850-2026Class IIIOngoingSep 16, 2026Fluphenazine Hydrochloride TabletsFailed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent...Ajanta Pharma USA Inc · D-0836-2026Class IIIOngoingSep 16, 2026Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic SolutionSubpotent DrugImprimisRx NJ LLC · D-0835-2026Class IOngoingSep 9, 2026Glutathione 200 mg/mLMicrobial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.Optimal Balance Pharmacy · D-0851-2026Class IOngoingSep 9, 20260.9% Sodium Chloride Injection USP 500 mLPresence of particulate matter: Particulates identified as fiberglassBaxter Healthcare Corporation · D-0849-2026Class IIOngoingSep 9, 2026Prasugrel HCIFailed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolutionGolden State Medical Supply Inc. · D-0847-2026Class IIIOngoingSep 9, 2026Buprenorphine Sublingual TabletsLabeling: Label Mix-upAmerican Health Packaging · D-0840-2026Class IIOngoingSep 9, 2026Prasugrel TabletsFailed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteriaMylan Pharmaceuticals Inc · D-0839-2026Class IIIOngoingSep 9, 2026RevcoviFailed Stability Specifications: Out of specification stability result for the protein concentration profile.Chiesi USA, Inc. · D-0838-2026Class IIOngoingSep 9, 20262% Chlorhexidine Gluconate* ClothCross Contamination with Other ProductsSage Products, LLC · D-0837-2026Class IIOngoingSep 9, 2026traZODone Hydrochloride TabletsPresence of Foreign Tablets/CapsulesTeva Pharmaceuticals USA, Inc · D-0834-2026Class IIIOngoingSep 9, 2026Trokendi XRFailed dissolution specifications.Supernus Pharmaceuticals, Inc. · D-0833-2026Class IIOngoingSep 9, 2026Carton label: Mycophenolate Mofetil for injectionFailed Dissolution SpecificationsMylan Pharmaceuticals Inc · D-0830-2026Class IIOngoingSep 9, 2026Broadway Joe's Pain CreamCGMP Deviations: Potential contamination of raw materialLexia LLC · D-0829-2026Class IIOngoingSep 9, 2026Broadway Joe's Pain CreamCGMP Deviations: Potential contamination of raw materialLexia LLC · D-0828-2026Class IIOngoingSep 9, 2026THE ONE SPF 50 INVISIBLE SUNSCREEN GELSubpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.Allies Group Inc. · D-0826-2026Class IIOngoingSep 9, 2026THE ONE SPF 50 INVISIBLE SUNSCREEN GELSubpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.Allies Group Inc. · D-0825-2026Class IIOngoingSep 9, 2026THE ONE SPF 50 INVISIBLE SUNSCREEN GELSubpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.Allies Group Inc. · D-0824-2026Class IIOngoingSep 9, 2026THE ONE SPF 50 INVISIBLE SUNSCREEN GELSubpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label.Allies Group Inc. · D-0823-2026Class IIIOngoingSep 9, 2026Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mgPresence of Foreign Tablets/CapsulesBionpharma Inc. · D-0822-2026Class IIOngoingSep 9, 2026DaptomycinCGMP DeviationsBaxter Healthcare Corporation · D-0821-2026Class IIOngoingSep 9, 2026Vancomycin InjectionCGMP DeviationsBaxter Healthcare Corporation · D-0820-2026Class IIOngoingSep 9, 2026VasopressinCGMP DeviationsBaxter Healthcare Corporation · D-0819-2026Class IIOngoingSep 9, 2026Clindamycin Injection USP in 5% DextroseCGMP DeviationsBaxter Healthcare Corporation · D-0818-2026